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tional measures to structural measures is expected to be more informative for the 
diagnosis.	Here,	we	aimed	to	assess	whether	multimodal	neuroimaging	measures	of	
structural and functional alterations could have potential for enhancing performance 






in combination in support vector machine classifiers for different problems of dis-




specific diagnostic types. The addition of functional measures to the structural meas-
ure	generally	yielded	statistically	significant	improvements	to	classification	accuracy,	
compared to the use of the structural measure alone.
Conclusion: We suggest the fusion of multimodal neuroimaging measures as an ef-
fective strategy that could generally cope with diverse prediction problems of clinical 
concerns.
K E Y W O R D S
functional	MRI,	machine	learning,	multiple	system	atrophy,	Parkinson's	disease,	progressive	
supranuclear	palsy,	structural	MRI
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1  | INTRODUC TION
In	the	era	of	precision	medicine,	machine	learning-based	predictive	
modeling has great potential for clinical prediction problems includ-
ing	the	diagnosis	of	specific	diseases,	as	 it	can	find	patterns	that	a	
single clinician may not detect when it is applied to various clinical 
data	sources.	However,	there	are	also	challenges	regarding	a	lack	of	
its meaningful contributions to clinical practice primarily due to the 
need	of	additional	measures	characterizing	 the	disease	process	as	
well	as	the	demand	for	a	large	sample	size	(Deo,	2015).
For	 the	diagnosis	of	Parkinson's	disease	 (PD)	 and	atypical	 par-
kinsonism	(AP),	though	still	usually	reliant	on	a	medical	history	and	
neurological	examination	in	clinical	practice,	neuroimaging	measures	
have	been	 increasingly	 employed.	 Furthermore,	 the	 application	of	
machine learning to neuroimaging measures has shown improved 
performance in classification problems related to the diagnosis (Rana 
et	al.,	2015;	Salvatore	et	al.,	2014).	In	particular,	given	challenges	of	
the	differential	diagnosis	between	PD	and	AP	as	often	manifested	
as	 the	 underdiagnosis	 of	 AP	 and	 the	 overdiagnosis	 of	 PD	 (Irene	
Litvan,	1999),	machine	learning-based	predictive	modeling	with	neu-
roimaging measures has emerged as an approach to discover new in-
sights	into	the	diagnosis	(Garraux	et	al.,	2013;	Scherfler	et	al.,	2016).
Among	other	MRI	measures,	gray	matter	(GM)	volume	acquired	
from	 structural	 MRI	 (sMRI)	 has	 been	 successfully	 employed	 for	








mains unclear whether the fusion of structural and functional mea-
sures could be more informative than the use of structural measures 





of	 AP.	We	wanted	 to	 search	 for	 an	 effective	 strategy	 that	would	
generally cope with such diverse diagnostic classification problems. 
Specifically,	 we	 sought	 to	 test	 whether	 multimodal	 neuroimaging	
measures of structural and functional abnormalities could help to 
enhance classification performance compared to the use of mono-




spectively	 from	2011	 to	2016	at	 a	 single	 tertiary	hospital,	 patients	
who	 underwent	 neurological	 examination,	 including	 the	 unified	
Parkinson's	disease	rating	scale	(UPDRS)	(Fahn,	Elton,	&	Members	of	
the	UPDRS	Development	 Committee,	 1987)	 and	mini-mental	 state	
examination	 (MMSE),	 and	 conventional	MRI	 scans	 at	 the	 first	 visit	
to	the	clinic,	were	selected.	At	 least	3	years	after	the	first	visit,	the	







cal features and drug responses during a follow-up were considered.
As	 diagnostic	 results,	 77	 patients	 (67.62	±	 7.72	 years,	 33	 fe-
males	 and	 44	 males)	 were	 diagnosed	 with	 PD	 and	 86	 patients	
(66.28 ±	9.24	years,	37	females	and	49	males)	were	diagnosed	with	
probable	AP.	The	patients	who	were	diagnosed	with	AP	were	 fur-
ther	 divided	 into	 44	 patients	 (61.73	±	 9.19	 years,	 18	 females	 and	


















axial planes with a T2*-weighted gradient-echo echo-planar imag-
ing	sequence:	repetition	time	=	2,000	ms,	echo	time	=	30	ms,	num-
ber of slices =	31,	slice	thickness	=	4.00	mm,	matrix	size	= 80 ×	80,	
and in-plane resolution =	 2.75	mm	×	 2.75	mm.	Using	 the	 tools	 in	
SPM12	 (http://www.fil.ion.ucl.ac.uk/spm/,	RRID:SCR_007037)	 and	






were obtained from rsfMRI. Details on how the neuroimaging data 
were	processed	 to	acquire	 the	structural	 and	 functional	measures	
are	described	in	Appendix	S1.
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2.3 | Statistical inferences on 
neuroimaging measures
At	a	group	level,	differences	in	the	voxel-wise	measures,	including	GM	
volume,	ReHo,	and	DegCen,	were	 inferred	using	 two-sample	 t tests 
between HC and each diagnostic type and between different diagnos-
tic	types.	In	the	voxel-wise	statistical	inferences,	influences	of	age,	sex,	
and years of education were adjusted commonly for the three meas-
ures,	and	an	effect	of	total	intracranial	volume	(TIV)	was	additionally	
adjusted	for	GM	volume.	Statistical	significance	was	determined	at	an	
extent threshold of a p value of .05 family-wise error corrected for mul-
tiple comparisons with a height threshold of a p value of .001.
2.4 | Generation of predictor sets and application of 
machine learning




vided	by	TIV,	ReHo,	 and	DegCen	averaged	over	 voxels	within	 the	
region were assigned. Since the collection of values according to the 
choice	of	a	specific	atlas	seems	to	be	arbitrary	in	acquiring	predictor	
values,	we	also	applied	the	same	predictive	modeling	procedure	de-






an	 SVM	 classifier	 for	 each	 classification	 problem,	 we	 evaluated	
classification	accuracy	via	leave-one-out	cross-validation,	by	which	
classification accuracy was computed for each left-out instance 
other than instances used for training. To assess improvements to 
classification accuracy according to the combined use of multimodal 
neuroimaging	measures	 in	 developing	 SVM	 classifiers,	we	 consid-




all the three measures. Each of the predictor sets was corrected for 
effects	 of	 age,	 sex,	 and	 years	 of	 education	 by	 obtaining	 residuals	
after regressing out the confounding covariates. To reduce the risk 
of	overfitting,	irrelevant	predictors	were	removed	when	they	failed	
to pass a criterion of showing a difference between two groups with 
a p value of.05 uncorrected for multiple comparisons in a two-sam-
ple t test.
2.5 | Comparison of classification accuracy
To	 compare	 classification	 accuracy	 between	different	 SVM	classi-
fiers,	specifically	between	the	one	constructed	with	the	structural	
measure alone and the ones constructed by the combination of the 
structural	and	functional	measures,	we	used	a	resampling	approach	
(Hothorn,	 Leisch,	 Zeileis,	 &	Hornik,	 2005)	 to	 derive	 a	 distribution	
of classification accuracy. Resampling was performed by applying 
10-fold	cross-validations	 iteratively	1,000	 times,	 such	 that	10,000	
estimates of classification accuracy were collected. The distribution 
of the estimates was represented as a curve the shape of which has 
been defined by a kernel smoothing function. With matched resa-
mpling	for	two	SVM	classifiers,	one-sided	one-sample	t tests were 
conducted	to	assess	the	null	hypothesis	of	zero	or	negative	differ-
ences in the estimates. Statistical significance was determined at a 
p value of .05 family-wise error corrected for multiple comparisons.











Sample	size 53 77 44 42
Age,	years	
(mean ± SD)
66.87	± 8.36 67.62	±	7.72 61.73	± 9.19 71.04	± 6.56 NS NS <.001
Sex	(female:male) 28:25 33:44 18:26 19:23 NS NS NS
Education,	years	
(mean ± SD)
12.53 ±	4.44 10.10 ±	4.75 11.43	±	4.38 10.27	±	4.89 .006 NS NS
Disease	duration,	
months (mean ± SD)
n/a 22.49	± 20.96 25.31 ±	18.94 33.33 ± 16.19 n/a .028 .040
UPDRS	(mean	± SD) 2.50 ± 2.12 24.90	± 10.32 29.67	± 13.36 28.00 ± 11.52 .003 NS NS
MMSE (mean ± SD) 28.33 ±	1.24 27.04	± 2.51 26.36 ± 3.26 24.31	±	2.78 .003 .006 NS
Abbreviations:	AP,	atypical	parkinsonism;	HC,	healthy	controls;	MMSE,	mini-mental	state	examination;	MSA,	multiple	system	atrophy;	NS,	
nonsignificant;	PD,	Parkinson's	disease;	PSP,	progressive	supranuclear	palsy;	UPDRS,	unified	Parkinson's	disease	rating	scale.
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involved	 in	 different	measures.	 In	 addition,	 as	 crucial	 roles	 of	 the	
cerebellum	in	PD	and	AP	have	been	noted	(Wu	&	Hallett,	2013),	we	
computed relative weight ratios of cerebral and cerebellar regions 
by	segregating	GM	regions	 involved	 in	each	measure	 into	the	two	
regions.
3  | RESULTS
3.1 | Demographic and clinical characteristics
Table	1	 summarizes	demographic	 and	 clinical	 characteristics	of	 all	
participants. The patients were matched in age and sex with HC de-
spite	PSP's	being	relatively	older	among	the	patients.	Motor	 func-
tion,	 as	 assessed	 with	 the	 motor	 section	 of	 the	 UPDRS,	 was	 not	
different	between	different	diagnostic	types.	Cognitive	function,	as	




3.2 | Group differences in neuroimaging measures
Figures	S1–S6	depict	differences	in	the	three	measures	between	HC	





basal	ganglia,	 thalamus,	cingulate	cortex,	 insula,	 superior	 temporal	




more	 severe	 primarily	 over	 the	 cerebellum	 in	 both	MSA	 and	 PSP	
compared	 to	PD,	 and	greater	 decreases	 in	GM	volume	were	 seen	
over	the	thalamus,	cingulate	cortex,	and	frontal	cortex	in	PSP	than	
in	MSA.
Differences in functional measures were also observed but not 
in	 all	 diagnostic	 types,	 and	group	differences	were	much	 less	 dis-
tributed	 than	 those	 seen	 for	GM	volume.	 In	 comparison	with	HC,	
decreases	 in	 ReHo	 were	 observed	 over	 the	 cerebellum	 in	 MSA,	
whereas reductions in DegCen were seen over the cingulate cortex 
commonly in PD and PSP and over the sensorimotor cortices as well 
in PD.
3.3 | Classification accuracy of SVM classifiers
A	heat	map	 in	Figure	1	exhibits	 variations	 in	 the	 classification	ac-
curacy	 of	 SVM	 classifiers	 according	 to	 different	 combinations	 of	
measures.	Also,	 for	 the	SVM	classifier	constructed	with	 the	struc-
tural measure alone and those composed by the combination of 
the	structural	and	functional	measures,	Figure	2	shows	probability	
density curves of classification accuracy estimates and Table 2 lists 
statistically significant differences in classification accuracy. In gen-
eral,	predictor	sets	composed	by	the	combination	of	the	structural	
and functional measures provided comparable or higher classifica-
tion accuracy compared to those constructed with a single measure 
across the different classification problems. The combination of all 
the three measures yielded the highest classification accuracy in 





higher than that yielded by the structural measure alone. When we 
assessed classification accuracy by applying the same predictive 
modeling	procedure	to	the	choice	of	different	atlases,	the	fusion	of	
more than two measures still tended to yield improvements to clas-
sification	 accuracy	 across	 the	 different	 classification	 problems,	 as	
displayed	in	Figures	S7	and	S8.
3.4 | Contributions of GM regions to classification
Figure	3	shows	predictors	in	the	SVM	classifier	that	has	been	com-
posed	by	the	combination	of	all	the	three	measures.	GM	regions	in-
volved in both the structural and functional measures were up to 
32%	of	cerebral	regions	in	distinguishing	between	MSA	and	PSP	and	
up	 to	71%	of	cerebellar	 regions	 in	distinguishing	between	PD	and	
MSA	 (Table	 S5).	 In	 terms	 of	 relative	weight	 ratios	 of	 cerebral	 and	
cerebellar	 regions	 (Figure	3),	 the	 relative	weight	 ratios	of	 cerebral	






sification	 problems,	which	 include	 distinguishing	 between	PD	 and	
AP	and	between	subtypes	of	AP	as	well	as	discriminating	PD	and	AP	
from	HC.	In	the	current	investigation,	as	an	effective	strategy	that	
can be used to tackle such diverse diagnostic classification prob-
lems,	we	proposed	employing	multimodal	neuroimaging	measures	in	
machine learning-based predictive modeling. We demonstrated that 
the combined use of the structural and functional measures could 
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improve	the	performance	of	SVM	classifiers,	compared	to	the	use	of	
the	structural	measure	alone,	for	most	of	the	classification	problems	
even when statistical group differences of the functional measures 
were not extensively seen.
As	machine	 learning-based	 predictive	 modeling	 has	 drawn	 at-
tention	in	the	era	of	precision	medicine,	the	potential	of	multimodal	







individual ones or combinations of those as predictor sets for various 
classification problems.






tural alterations may be described in terms of differential involve-
ments of cerebral and cerebellar regions: Cerebral regions were 
mainly	affected	in	PD;	cerebellar	regions	in	MSA;	and	both	cerebral	
and cerebellar regions in PSP.






and	 functional	 alterations,	 reflects	 a	 link	 between	 structural	 and	
functional abnormalities.
When the structural and functional measures were employed 
as predictor sets for discriminating each diagnostic type from HC 
and	 distinguishing	 between	 different	 diagnostic	 types,	 statistical	
group differences were not always directly connected with the 
performance	of	SVM	classifiers.	For	instance,	although	GM	volume	
was the measure of the most prominent differences between HC 
and	PD	at	a	group	level,	it	yielded	lower	classification	performance	
than	the	functional	measures.	Nevertheless,	when	we	combined	the	
structural	 and	 functional	measures	 in	 constructing	 predictor	 sets,	
classification	performance	became	generally	enhanced,	and	particu-
larly,	the	combination	of	all	the	three	measures	yielded	significantly	
higher classification accuracy than the structural measure alone in 
all	classification	problems	but	distinguishing	between	PD	and	MSA.	
As	it	is	already	recognized	in	clinical	practice	that	multiple	diagnos-
tic criteria help to increase the level of diagnostic accuracy (Irene 
Litvan,	1999),	the	addition	of	the	functional	measures	seems	to	yield	
enhanced classification performance by providing additional diag-







it would be obvious as well that not all aspects of the distinction 
between groups can be explained by structural alterations alone 
even when functional alterations are not clearly revealed in sta-
tistical	 comparisons	 at	 a	 group	 level.	 As	 shown	 in	 Figure	 3,	 the	
involvement	of	a	substantial	portion	of	GM	regions,	including	the	
F I G U R E  1  A	heat	map	of	the	
classification accuracy of support 
vector	machine	(SVM)	classifiers	for	
different classification problems. In the 
SVM	classifiers,	individual	measures	or	
combinations of those were employed 
as predictor sets. The considered 
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sensorimotor	 cortices,	 cingulate	 cortex,	 and	 cerebellum	 men-
tioned	 above,	 in	 predictors	 of	 both	 structural	 and	 functional	
measures indicates again a link between structural and functional 
abnormalities.	Moreover,	local	and	global	functional	measures	had	
different	 contributions	 to	 classification,	 so	 that	 the	 inclusion	 of	
both functional measures would be largely helpful in enhancing 
classification performance.
With respect to the notion that multimodal neuroimaging mea-
sures can be fused to generally improve performance for various 
prediction	problems,	 it	might	be	tempted	to	add	as	wide	a	variety	
of	 measures	 as	 available.	 However,	 it	 is	 also	 important	 to	 under-
stand that improvements to prediction performance can be not al-
ways guaranteed by the combined use of multimodal neuroimaging 
measures	(Schmaal	et	al.,	2015).	In	this	regard,	requirements	for	en-
hanced prediction performance may be mentioned in two aspects. 
First,	 informative	 measures	 that	 can	 characterize	 the	 pathogen-
esis or pathophysiology of a disease need to constitute predictors 
for	 machine	 learning	 (Deo,	 2015).	 As	 additional	 informative	 MRI	
measures,	 for	 instance,	white	matter	 structural	measures	 that	can	
be	 acquired	 from	 diffusion	weighted	MRI	would	 be	 promising,	 as	




portant	measures	 or	 combining	 existing	measures.	Here,	we	 used	
the	filter	method	as	a	simple	way	of	feature	reduction,	but	a	more	
advanced approach to feature reduction could be considered (Meng 
et	al.,	2017).	Alternatively,	deep	learning	may	be	employed	since	it	
provides the capability of data-driven automatic feature generation 
(Arbabshirani,	Plis,	Sui,	&	Calhoun,	2017).
This	study	has	limitations	to	consider.	For	each	diagnostic	type,	
although clinical diagnoses were finally made after more than 
three years	 of	 a	 clinical	 follow-up,	 the	 possibility	 of	misdiagnosis	
cannot be ruled out due to a lack of pathological confirmation. 
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Vol + ReHo Vol + DegCen Vol + ReHo + DegCen
HC versus PD 0.083 (p value <	.001) 0.079	(p value <	.001) 0.119 (p value <	.001)
HC	versus	MSA NS 0.005 (p value <	.001) 0.047	(p value <	.001)
HC versus PSP 0.036 (p value <	.001) 0.075	(p value <	.001) 0.076	(p value <	.001)
PD	versus	MSA NS 0.004	(p value <	.001) NS
PD versus PSP 0.063 (p value <	.001) 0.023 (p value <	.001) 0.055 (p value <	.001)




mean difference in classification accuracy and its respective p value are listed.
Abbreviations:	HC,	healthy	controls;	MSA,	multiple	system	atrophy;	NS,	nonsignificant;	PD,	
Parkinson's	disease;	PSP,	progressive	supranuclear	palsy.
TA B L E  2   Statistically significant 
differences in classification accuracy 
between	support	vector	machine	(SVM)	
classifiers
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In	 addition,	 as	 regards	 our	machine	 learning	 approach,	 the	 sam-
ple	size	 in	 this	 study	was	small,	and	moreover,	 the	generalization	
ability of the predictive models was not fully evaluated in that we 
performed	 internal	 cross-validation	 only.	 Further	 investigation	




Although	 structural	 and	 functional	 abnormalities	may	be	 specific	
to	 individual	MSA	variants	 (Planetta	et	al.,	2015),	we	merged	the	
two	phenotypes	of	MSA	as	a	single	group	here	primarily	due	to	a	
possible overlap of clinical and pathological findings between the 
two	(Krismer	et	al.,	2019;	Wenning	et	al.,	2013)	 in	relation	to	our	
limited	sample	size	of	each.
In	 conclusion,	 we	 demonstrated	 that	 the	 fusion	 of	 different	
measures from multimodal neuroimaging would have potential for 
improving the performance of machine learning-based predictive 
models.	For	PD	and	AP,	although	functional	alterations	are	much	
more	 limited	 than	 structural	 alterations,	 a	 possible	 link	 between	
structural and functional abnormalities appears to support the 
informativeness	 of	 functional	 measures,	 and	 the	 combined	 use	
of structural and functional measures is likely to yield improve-
ments to performance in various diagnostic classification prob-
lems. In machine learning approaches to predictive modeling for 
clinical	concerns,	the	limited	sample	size	has	been	a	major	obstacle	
(Sakai	 &	 Yamada,	 2019).	 Although	 it	may	 be	 often	 unsure	which	
neuroimaging measures would be suitable for a specific prediction 
problem,	we	propose	that,	in	addition	to	increasing	the	number	of	
patients,	gathering	diverse	informative	measures	from	multimodal	





aged by taking advantage of recent technical advances toward the 
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